Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Supplemented OMV vaccine against meningococcus
No-Receipt date
2014-02737 - 17/09/2014
No-Filing date
20140401891 - 17/09/2014
No-Granting date
3084343 - 25/09/2014
No-EPO application date
07013453.1 - 17/01/2001
No-EPO granting date
1897555 - 16/07/2014
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
9/2014 - 17/10/2014
Expiration date
18/01/2021
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
GB000106717/01/2000/GB
GB000569909/03/2000/GB
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 31/00
A61K 39/295
A61K 39/116
A61K 39/095
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
683342
GLAXOSMITHKLINE BIOLOGICALS S.A.
RUE DE L`INSTITUT, 89
1330 RIXENSART, BELGIUM
BELGIUM
Inventors
Code
Firstname
Surname
1333507
PIZZA, MARIAGRAZIA
1333508
RAPPUOLI, RINO
1333509
GIULIANI, MARZIA
Representatives
Code
Firstname
Surname
Address
Town
Zip
742
KONSTANTINOS
KILIMIRIS
XATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2119
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
18/09/2017
Μεταβίβαση (7e802)
Α.Π.3989-Η.Θ.9170/18-7-17,ΔΝΥ1199,ΚΩΔ.ΠΛΗΡ.3190
553713 Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina 1 ΙΤΑΛΙΑ 53100 Siena (SI)
683342 GlaxoSmithKline Biologicals S.A. Rue de l`Institut, 89 ΒΕΛΓΙΟ 1330 Rixensart, BELGIUM
Title Instruments
Date
Operation
Descreption
8/2/2018 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 07 / 2018 Αρ. Πρωτ. ΓΔ 1833 / 02-08-2018
Payments history
17 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).